Company Filing History:
Years Active: 2008
Title: Christan Muenz: Innovator in Vaccine Development
Introduction
Christan Muenz is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines. His work focuses on the Epstein Barr Virus (EBV), which is known for its association with various diseases.
Latest Patents
Christan Muenz holds a patent for a protective antigen of the Epstein Barr Virus. The invention relates to the identification of a subunit vaccine aimed at preventing or treating EBV infections. Specifically, EBNA-1 has been identified as a vaccine antigen. In a specific embodiment, a purified protein corresponding to EBNA-1 elicited a strong CD4T cell response. The responsive CD4T cells are primarily T1 in function. EBNA-1 is considered an attractive candidate for a protective vaccine against EBV, as well as for immunotherapy of EBV infection and neoplasms, particularly when used with dendritic cells charged with EBNA-1.
Career Highlights
Christan Muenz is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the understanding of EBV and its potential treatments.
Collaborations
One of his notable collaborators is Ralph M. Steinman, who has also made significant contributions to immunology. Their partnership highlights the importance of teamwork in scientific research.
Conclusion
Christan Muenz's innovative work in vaccine development against the Epstein Barr Virus showcases his dedication to advancing medical science. His contributions are vital for future therapeutic strategies against EBV-related diseases.